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Rheumatoid arthritis (RA) is an inflammatory disease with a complex genetic component. An association between
RA and the human leukocyte antigen (HLA) complex has long been observed in many different populations, and
most studies have focused on a direct role for the HLA-DRB1 “shared epitope” in disease susceptibility. We have
performed an extensive haplotype analysis, using 54 markers distributed across the entire HLA complex, in a set
of 469 multicase families with RA. The results show that, in addition to associations with the DRB1 alleles, at
least two additional genetic effects are present within the major histocompatibility complex. One of these lies within
a 497-kb region in the central portion of the HLA complex, an interval that excludes DRB1. This genetic risk
factor is present on a segment of a highly conserved ancestral A1-B8-DRB1*03 (8.1) haplotype. Additional risk
genes may also be present in the HLA class I region in a subset of DRB1*0404 haplotypes. These data emphasize
the importance of defining haplotypes when trying to understand the HLA associations with disease, and they
clearly demonstrate that such associations with RA are complex and cannot be completely explained by the DRB1
locus.
Introduction
Rheumatoid arthritis (RA [MIM 180300]) is an inflam-
matory disease with autoimmune features, the etiology
of which is still unknown. An association between RA
and human leukocyte antigens (HLA) was first dem-
onstrated in the 1970s, when the mixed lymphocyte cul-
ture (MLC) type Dw4 was found to be present at in-
creased frequencies among patients with RA compared
with control individuals (Stastny 1978). Since then, a
large number of population studies have confirmed the
association between RA and HLA-DRB1*04 (Ollier and
Thomson 1992). The size of the genetic component in
RA has been computed using the relative recurrence risk
for siblings of probands with RA (ls); it is likely that
this value lies between 5 and 10 (Seldin et al. 1999;
Jawaheer et al. 2001). It has been estimated that ap-
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proximately one-third to one-half of this total genetic
contribution in RA can be attributed to genes in theHLA
complex, also known as the “major histocompatibility
complex” (MHC) (Deighton et al. 1989). In two sepa-
rate genomewide screens using affected sibling pairswith
RA, it was demonstrated that HLA has the largest ge-
netic contribution in RA, and the relative contribution
of HLA genes (lHLA) was found to be 1.7–1.8 (Cornelis
et al. 1998; Jawaheer et al. 2001). However, despite 120
years of research to unravel the role of HLA in RA, the
exact cause of this association remains unknown.
The vast majority of studies have focused on a direct
role for DRB1 alleles that encode a common structural
element, designated the “shared epitope” (Gregersen et
al. 1987). However, it is unlikely that the shared epitope
alone can completely explain the HLA-associated risk
for RA (Moxley and Cohen 2002). Different shared
epitope-encoding DRB1 alleles vary in the strength of
their association with RA, suggesting additional allelic
or haplotypic effects on risk. In addition, particular heter-
ozygote combinations that have identical combinations
of shared epitope sequences may, nevertheless, differ
dramatically in their relative risk (RR) for RA. For ex-
ample, a RR of 6.4 is associated with the DRB1*0101/
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Table 1
Structure of the Multiplex Families with RA
NO. OF PARENTS
AVAILABLE
NO. OF FAMILIES
(n p 469)
NO. OF FAMILIES WITH
2 Affected Sibs 3 Affected Sibs 4 Affected Sibs 6 Affected Sibs
2 59 56 3 0 0
1 164 146 18 0 0
0 246 212a 29b 4c 1d
a Two families had one unaffected sibling genotyped.
b Three families had one, two, and five unaffected siblings genotyped.
c One family had five unaffected siblings genotyped.
d One family had one unaffected sibling genotyped.
0401 genotype, but, for the DRB1*0401/0404 geno-
type, the RR is 31.3 (Hall et al. 1996). The HLA shared
epitope does not show an association with RA among
African-American and Hispanic-American RA pop-
ulations (McDaniel et al. 1995; Teller et al. 1996).
Moreover, when the marker association-segregation
x2 method is used to investigate the HLA component
in RA, a role for the shared epitope in RA is rejected
(Dizier et al. 1993).
The HLA complex occupies a 3.6-Mb region on the
short arm of chromosome 6 (6p21.3 band) and contains
∼220 defined genes (Milner and Campbell 2001). Many
of the genes in this region are involved in immune func-
tion. However, aside from DRB1, the only other locus
within the MHC that has been reported as a possible
candidate for RA susceptibility is the tumor necrosis
factor (TNF) locus (Mulcahy et al. 1996; Ota et al.
2001; Waldron-Lynch et al. 2001). In the present study,
we have used 54 polymorphic markers to examine HLA
haplotypes in 469 multiplex families with RA (Greger-
sen 1998; Jawaheer et al. 2001). This has allowed us
to define additional genetic regions within the MHC,
in addition to DRB1, that confer risk of RA. These data
emphasize the importance of defining haplotypes when
trying to understand the HLA associations with disease,
and they clearly demonstrate that these associations
with RA are complex and cannot be completely ex-
plained by the DRB1 locus.
Subjects and Methods
Study Populations
Participants in the present study were members of 469
white families with multiple cases of RA who were
drawn from the North American Rheumatoid Arthritis
Consortium (NARAC) collection. The number of par-
ents and affected siblings who participated in the study
are shown in table 1. Parental DNA samples were avail-
able for typing in 223 families. Among those families
for which parental DNA was unavailable, 7 families had
DNA from unaffected siblings of the proband. The clin-
ical characteristics of these families have been described
elsewhere (Gregersen 1998; Jawaheer et al. 2001).
Laboratory Procedures
DNA samples from the RA multicase families were
isolated from the mononuclear peripheral blood cells,
using a salting-out kit (BIO-101). Fifty-three microsat-
ellite markers distributed throughout the HLA complex
were used (fig. A [online only] and table A [online only]).
These included 5 TNF markers (TNFa–e) (Udalova et
al. 1993), 35 HLA markers described elsewhere (Nair
et al. 2000), and 13 markers (labeled “MN6Sxxxx”)
that were developed in a collaboration between the Gre-
gersen and Behrens laboratories (Graham et al. 2002 [in
this issue]). The exact marker locations were determined
from University of California, Santa Cruz, Genome
Bioinformatics Web site and the Web site of the Sanger
Institute. Fluorescent genotyping was performed using
amplification in 96-well plates under standard PCR
conditions (as described on the Web site of the Center
for Medical Genetics, Marshfield Medical Research
Foundation), pooling of PCR products using a Tecan
MiniPrep 75, and electrophoresis of the pooled PCR
products on a 3700 DNA Analyzer (Applied Biosys-
tems). Three of the markers, TNFb, D6S2669, and
D6S2681, required an annealing temperature of
66C, instead of 55C, in the PCR.
Broad-level HLA-DRB1 typing and high-resolution
DRB1*04 typing were accomplished by initial PCR am-
plification of groups of alleles (all DRB1 alleles for
broad-level typing and group-specific amplification for
DRB1*04 alleles) using biotinylated PCR primers, fol-
lowed by hybridization to immobilized sequence-specific
oligonucleotide probes in a linear-array format. Pos-
itive hybridization reactions were detected using a
streptavidin-horseradish peroxidase conjugate and a
soluble colorless substrate, 3,3′, 5,5′-tetramethylbenzi-
dine (Erlich et al. 1991). A computer algorithm, based
on the sequence-specific oligonucleotide–probe hybrid-
ization pattern, and the A. Nolan Immunogenetics/HLA
Sequence Database (1999) were used to assign genotypes
to each sample.
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Figure 1 Results of the single-marker PDT analysis. The log10 of the P value obtained from the global PDT (Y-axis) is plotted against
the order in which the markers are arranged across the HLA complex (X-axis). In addition to DRB1, four markers within the class III region
show a significant association ( ) with RA. The association with marker D6S2656 (allele 8), just centromeric to DRB1, reflects strongP ! .005
linkage disequilibrium with DRB1*04 alleles. However, as discussed in the text, the marker associations at TNFb (allele 3), TNFa (allele 2),
TNFd (allele 3), and D6S2669 (allele 9) reflect an association with a portion of the ancestral A1-B8-DRB1*03 (8.1) haplotype. See table A to
correlate marker numbers with marker names and actual position (fig. A).
Data Analysis
The raw data were analyzed using the GENESCAN
analysis (version 3.5) and GENOTYPER (version 2.1)
software packages (Applied Biosystems). Each genotype
was read independently by two individuals, to ensure
accurate calling of alleles. PedCheck was used to identify
any inheritance errors in the family data.
Association analysis.—To test for association, we used
a modified version of the Pedigree Disequilibrium Test
(PDT) (P. Stuart, personal communication), a family-
based association analysis program using untransmitted
alleles as control samples and transmitted alleles as cases
(Martin et al. 2000); it considers parent–affected child
triads and discordant sib pairs as the basis unit. The
modified version of the PDT program includes parent–
affected child dyads as well as triads and discordant sib
pairs. In the PDT test result, the overall P value, as well
as the P value for testing uneven frequencies in trans-
mitted and untransmitted groups for an individual allele,
are reported.
Haplotype analysis.—We used the GENEHUNTER
program to reconstruct haplotypes from the genotyping
data from the 469 families with RA (Kruglyak et al.
1996). To ensure the accuracy of these haplotypes, the
SIMWALK program (Sobel and Lange 1996) was also
used for haplotype reconstruction. A Perl program (W.
Li, unpublished data) was then utilized for discovery
of haplotype blocks. Detection of conserved haplotype
patterns among the haplotypes we reconstructed was
achieved by finding the most common three-markermini-
haplotype at each window position (1-2-3, 2-3-4,…, and
52-53-54). When such a three-marker minihaplotype can
be extended to the neighboring window, it indicates the
existence of a longer conserved haplotype. For any par-
ticular minihaplotype of interest (e.g., portion of the
ancestral A1, B8, DRB1*03 8.1 [8.1] haplotype), their
frequencies in two groups (i.e., transmitted and untrans-
mitted haplotypes) can be tested by a simple x2 test.
When the sample sizes are small, Fisher’s exact test can
be used to replace the x2 test. If the two groups are case
and control genotypes, the haplotype information is un-
known. In that case, the presence of a minihaplotype of
interest is determined by a partial presence of the marker
allele in the genotype. This method will tend to over-
estimate control haplotype frequencies and thus is a con-
servative approach for identification of positively asso-
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Figure 2 A three-marker “moving window” used to assess the similarity of transmitted (solid line; with dots in panels A and C) and
untransmitted (dashed line) haplotypes to the ancestral 8.1 haplotype consensus sequence. The frequency of three-marker windows matching
the “consensus” 8.1 haplotype sequence (Y-axis) is plotted against marker positions (X-axis). Marker positions and correspondingmarker names
are listed in table A. The sample sizes for the transmitted (T) and untransmitted (U) haplotypes are also shown. A, When all haplotypes have
DRB1*0301, the transmitted haplotypes are more similar to the consensus sequence than are the untransmitted haplotypes. B, The same pattern
is observed for DRB1*01, *15/*16, and *0401 but not for *0404. C, The combined data from all non-DRB1*0301 haplotypes are summarized
(top panel) (details shown in figure B). It also shows that the transmitted haplotypes are significantly different ( ) (bottom panel) fromP ! .05
the untransmitted ones in the interval between D6S2678 and MN6S2021.
ciated allelic combinations found on minihaplotypes of
adjacent markers.
Calculations of entropy.—To characterize the diversity
of haplotypes, we calculated an entropy measure of the
three-marker minihaplotypes. In this measure, frequency
counts of all minihaplotypes were determined { }p 1 0i
( ), where m is the number of minihaplo-ip 1,2,… ,m
types observed. The normalized entropy is defined as
if , and , ifEp  p log (p )/ log (m) m 1 1 Ep 0i i i
, and is a measure of the diversity of minihap-mp 1
lotypes in the “observed data.” If all minihaplotypes are
evenly distributed, then . On the other hand, if aEp 1
single haplotype is far more frequent than other hap-
lotypes, then E approaches 0. It can be shown that the
normalized entropy is related to the likelihood L of a
multinomial distribution as ,Lp exp [N log (m)E]
where N is the sample size.
Results
To further investigate which portion(s) of the HLA com-
plex are associated with RA, we used genetic markers
distributed across the MHC to examine patterns of
transmission disequilibrium in a panel of 469 families
with RA that included affected sibling pairs. Each of
these markers was independently tested for disease as-
sociation, using a modified version of the Pedigree Dis-
equilibrium Test (PDT), which included dyads as well
as triads in the analysis (see the “Subjects andMethods”
section). As expected, the strongest association was
observed with DRB1 (DRB1*0401, ;9Pp 7# 10
DRB1*0404, ). However, as shown in fig-5Pp 6# 10
ure 1, a number of markers in the HLA class III region
also showed a significant association with RA. Among
these were TNFb (allele 2 [ ] and allele3Pp 8.15# 10
3 [ ]), TNFa (allele 2 [3Pp 3.33# 10 Pp 9.67#
]), TNFd (allele 3 [ ]), and D6S26695 310 Pp 1.12# 10
(allele 9 [ ].4Pp 3.28# 10
Simple inspection of the data showed that the com-
bination of TNF b3-a2-d3 and D6S2669 allele 9 formed
a common haplotype. We anticipated that this haplo-
type would be in linkage disequilibrium with one or
more HLA-DRB1 alleles, possibly DRB1*0401 or
*0404. Using the GENEHUNTER analysis package, we
reconstructed full haplotypes wherever possible from
the available genotyping data. Surprisingly, after se-
lecting for haplotypes bearing the TNF b3-a2-d3 and
D6S2669-9 allele combination among the probands, we
found that the DRB1*0301 allele (not DRB1*0401 or
*0404) was present on 52 (95%) of the 55 haplotypes.
When selecting for only those haplotypes with the TNF
allele combination TNF b3-a2-d3 (without allele 9 of
D6S2669), 66 (61%) of the 108 haplotypes had a
DRB1*0301 allele. Furthermore, we observed that
the allelic combination of TNF b3-a2-d3 and D6S2669-
9 is part of a conserved ancestral DRB1*0301-bearing
haplotype (A1-B8-DRB1*03, also known as the 8.1
haplotype), which occurs frequently in white individuals
(Price et al. 1999; Graham et al. 2002 [in this issue]).
To determine whether portions of the 8.1 ances-
tral haplotype are present on haplotypes without
DRB1*0301, all haplotypes were grouped according to
their broad HLA-DRB1 type. In addition, within each
group, the haplotypes were stratified as transmitted or
untransmitted, depending on whether they were trans-
mitted to an affected offspring. We then examined a
three-marker “window” of allelic combinations by con-
secutively moving this window across the entire HLA
complex (1-2-3, 2-3-4,…, and 52-53-54). For eachDRB1
haplotype group, the percent similarity of each three-
marker minihaplotype to the consensus 8.1 haplotype
was determined. As can be seen from the pattern shown
in figure 2A, among the DRB1*0301-bearing haploty-
pes, the transmitted haplotypes shared a portion of the
consensus 8.1 haplotype more often than did the un-
transmitted haplotypes. Furthermore, as shown in
figure 2B, in several haplotypes that do not bear
DRB1*0301, there is still a tendency for the transmitted
haplotypes to contain segments of the ancestral 8.1 hap-
lotype, particularly in the midportion of the HLA
complex. (The data for all the major DRB1 haplotype
groups are shown in figure B [online only]). When all
the non-DRB1*0301 haplotypes were combined and
analyzed as a group (fig. 2C), the three-marker mini-
haplotypes matching the ancestral al 8.1 haplotype were
present significantly more frequently on transmitted
haplotypes than on untransmitted haplotypes. Overall,
evidence for linkage disequilibrium with an RA disease-
susceptibility locus extends from marker D6S2678 to
marker MN6S2021 on this haplotype. Notably, this re-
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Figure 3 Normalized entropy plots for the transmitted (solid line) and untransmitted (dashed line) haplotypes in the DRB1*01 and *0404
haplotype groups. (For marker names, see table A.) The DE value given for each plot reflects the difference in diversity between untransmitted
and transmitted haplotypes. DRB1*01 haplotypes do not display a large difference in diversity between transmitted and untransmittedhaplotypes.
By contrast, for the DRB1*0404 haplotypes, DE is strongly positive, and this reflects the much lower diversity (lower E value) among transmitted
haplotypes compared to the untransmitted haplotypes. As discussed in the text and shown in figure 3, the lower diversity among DRB1*0404
transmitted haplotypes cannot be explained by the presence of sequences derived from the 8.1 conserved haplotype. E values for other haplotype
groups appear in figure C.
gion does not encompass the DRB1 locus, an obser-
vation consistent with the fact that the DRB1*0301
allele itself shows no association with RA ( forPp .62
single-marker PDT). Interestingly, this risk region does
not include the D6S2669 marker either, which showed
a significant association with RA in the PDT analysis.
We also investigated whether there are any additional
factors on the transmitted haplotypes within eachDRB1
group that might be different from the untransmitted
haplotypes. In order to address this question in a general
way, we used a novel approach of measuring the overall
diversity of the transmitted and untransmitted haplo-
types, in terms of the normalized entropy (E) (Shannon
1948). If combinations of alleles are fully randomized
in a collection of haplotypes, . Conversely, if aEp 1
single haplotype dominates the collection, E approaches
0. In most cases, there was no significant difference in
the E value between the transmitted and untransmitted
haplotypes (DE value), as shown in figure 3 (top panel)
for the DRB1*01 haplotypes (also see fig. C [online
only]). However, the transmitted DRB1*0404 haplo-
types were less diverse than the untransmitted ones (fig.
3, bottom panel), suggesting that a conserved portion
of the DRB1*0404 haplotype could harbor a genetic
risk factor for RA that is independent of, or interacting
with, DRB1*0404.
As shown in figure 2B, the transmitted DRB1*0404
haplotypes do not preferentially bear portions of the
8.1 ancestral haplotype. Therefore, we looked for other
consensus sequences that might associate with RA on
these DRB1*0404 haplotypes. Interestingly, a group of
three-marker haplotypes in the class I region are pref-
erentially found on transmitted haplotypes (see table 2).
These data indicate that a region of ∼659 kb contains
a gene that modifies the degree of risk conferred by
DRB1*0404 haplotypes. This region (from marker
D6S2703 to D6S2696) is located just centromeric to the
HLA-A locus. Thus, it does not overlap with the risk
region found on the ancestral 8.1 haplotype.
The analyses described abovewere performed on hap-
lotypes generated by the GENEHUNTER program, us-
ing only families in which these haplotypes could be
clearly defined. A comparison of the haplotypes gen-
erated by GENEHUNTER with those generated by
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Table 2
Comparison of Three-Marker Minihaplotypes in Transmitted vs. Untransmitted DRB1*0404
Haplotypes in Families with RA
MARKER ALLELES ATa MATCH/TOTAL IN
PM7 M8 M9 M10 M11 M12 M13 Transmitted Untransmitted
21 4 5 16/72 0/20 .019
4 5 2 19/67 0/20 .0048
5 2 6 29/66 3/23 .011
2 6 1 20/63 2/22 .048
6 1 2 17/63 1/24 .019
NOTE.— Five consecutive three-marker windows (7-8-9, …, 11-12-13) corresponding to the
interval between markers D6S2702 (marker 7) and D6S2691 (marker 13) showed a significant
difference between the number of transmitted DRB1*0404 haplotypes that match the
DRB1*0404 consensus haplotype and the number of untransmitted haplotypes that match the
consensus.
a Markers are as follows: M7 p D6S2702, M8 p D6S2700, M9 p D6S2699, M10 p
D6S2698, M11 p D6S2697, M12 p D6S2696, and M13 p D6S2691.
SIMWALK showed that, for pedigrees with at least one
parent typed, the reconstructed haplotypes from the two
programs were very similar. In contrast, for pedigrees
with none of the parents typed, the two programs often
led to quite different reconstructed haplotypes.
Therefore, for minihaplotype analyses, we generally
restricted ourselves to those pedigrees with one or
two parents typed ( ; see table 1), withnp 223
clearly defined haplotypes. The results of the three-
marker minihaplotype analyses using haplotypes con-
structed by GENEHUNTER (figs. 2A–2C and 3) were
highly similar to those generated using SIMWALK hap-
lotypes (data not shown).
Discussion
In the present study, we have comprehensively analyzed
the role of MHC haplotypes in genetic susceptibility for
RA. To perform these analyses, we were fortunate to
have available one of the largest existing collections of
multiplex families with RA, assembled over the last five
years by the North American Rheumatoid Arthritis Con-
sortium (Gregersen 1998). Overall, the results strongly
suggest that considerable genetic heterogeneity underlies
the linkage of HLA to this disease and that at least two
genetic regions other than HLA-DRB1 contribute to risk
of RA.
First, the data show that the central portion of the
ancestral 8.1 (A1-B8-DRB1*03) haplotype contains one
or more risk factors for RA. This is consistent with
previous reports that marker alleles in the TNF region
may be associated with RA (Mulcahy et al. 1996; Ota
et al. 2001; Waldron-Lynch et al. 2001), since the TNF
gene is present within the risk haplotype that we have
defined. Several of these studies have suggested that the
RA-associated TNF alleles may be found on a DRB1*03
haplotype (Mulcahy et al. 1996; Zanelli et al. 2001).
However, to our knowledge, the present analysis is the
first study to comprehensively define the extent of this
risk haplotype and its relationship to the ancestral 8.1
haplotype. Our data indicate that risk genes could be
present anywhere in a relatively large genomic region
extending from HLA-C to the C4 locus. Maximal sig-
nificance appears to be localized around the TNF gene
complex in the family-based association analysis reported
here. However, a separate case-control analysis (data not
shown) continues to show a broad region of association
extending to ∼500 kb. Nevertheless, it is of interest that
high TNF production is associated with TNF alleles
found on the ancestral 8.1 haplotype (Wilson et al.
1997), and this may explain the association observed
with RA. A recent study also raised the possibility that
HLA-C alleles could be risk factors for some forms of
RA (Yen et al. 2001). However, there are ∼50 genes in
this region of interest (MCH Sequencing Consortium
1999), and a significant proportion of these genes are
related to immune function. Therefore, it is difficult to
determine which genes in this region are actually re-
sponsible for the association we have observed.
The 8.1 haplotype is carried by most white indi-
viduals with HLA-B8 and has been associated with
a variety of interesting immunological diseases and phe-
notypes (Price et al. 1999). These include common var-
iable immunodeficiency (MIM 240500) and immuno-
globulin A (IgA) deficiency (MIM 137100), as well as
a number of autoimmune diseases, such as systemic lu-
pus erythematosus (MIM 152700]), insulin-dependent
diabetes mellitus (MIM 222100) and autoimmune hep-
atitis (MIM 142395). In the setting of vaccination or
viral infection, the A1-B8-DRB1*03 haplotype has been
associated with relative lack of responsiveness (Alper et
al. 1989), as well as accelerated progression of HIV
disease (Kaslow et al. 1990). Interestingly, this may ex-
tend to immune responses to Epstein-Barr–virus infec-
592 Am. J. Hum. Genet. 71:585–594, 2002
tion (Caruso et al. 1993), which has been proposed as
a potential etiologic agent in RA and other autoimmune
diseases (Tosato et al. 1981; James et al. 2001). These
findings may reflect regulation of the immune response
by classical HLA molecules. However, a variety of more
nonspecific immunological parameters have also been
associated with the 8.1 haplotype (Price et al. 1999),
particularly involving the regulation of cytokine pro-
duction (Candore et al. 1994; Lio et al. 2001). Overall,
there appears to be something immunologically distinct
about the 8.1 haplotype, and our data suggest that the
special immunological properties of the 8.1 haplotype
may contribute to the pathogenesis of RA.
Our analysis has also revealed evidence for a second
genetic effect on RA susceptibility within the class I
region of some DRB1*0404 haplotypes. Subsequent
to the identification of DRB1*0404 as a risk factor
for RA in the 1980s (Nepom et al. 1986), there have
been hints that DRB1*0404 haplotypes may play a
distinct role in susceptibility to RA. In particular, al-
though the DRB1*0404 allele alone appears to confer
a modest risk for RA (Ronningen et al. 1992; Thomson
et al. 1999), the compound heterozygote DRB1*0401/
*0404 displays very high RR (Hall et al. 1996).
The results of the present study confirm a high RR
for the compound heterozygote DRB1*0401/0404
( ; ). In addition, a subsetRRp 19.32 95%CIp 6–63
of DRB1*0404 haplotypes contain a common set of
minihaplotypes in the class I region, which confers
risk independent of the DRB1*0404 allele (table 2). The
region of interest extends over 600 kb and contains ∼12
functional genes, including HLA-E, a ligand for mem-
bers of the immunoglobulin-like killer inhibitory recep-
tor family, as well as other candidates of potential in-
terest (MHC Sequencing Consortium 1999).
In summary, we have shown that the contribution of
the MHC to genetic risk for RA involves two genetic
regions in addition to the DRB1 locus. These results
emphasize the utility of using haplotypic analysis, in-
stead of single-marker analysis, to dissect these genetic
effects. At the same time, the extensive linkage dis-
equilibrium within the human MHC (Jeffreys et al.
2001) will make it difficult to identify precisely which
gene or genes are responsible for these associations. It
is possible that larger sample sizes may lead to the iden-
tification of ancestral recombinants that will allow fur-
ther narrowing of these critical regions. This will also
provide adequate statistical power to define interactions
between these risk factors, which appear to exist in
DRB1*0401/*0404 compound heterozygotes and can
now be addressed with respect to the 8.1 ancestral hap-
lotype. Nevertheless, the identification of the risk genes
in these regions will be challenging and, ultimately, will
depend on relating candidate polymorphisms to the spe-
cific biological alterations that are involved in disease
pathogenesis.
Acknowledgments
This work was supported by National Institutes of Health
grants R01-AR44222 and N01-AR7-2232 (to P.K.G.) and
R01-AR43274 and P01-AR45231-SCOR in SLE (to T.W.B.).
These studies were performed, in part, in the General Clinical
Research Center, Moffitt Hospital, University of California,
San Francisco, with funds provided by National Center for
Research Resources grant 5-M01-RR-00079. The NARAC in-
cludes a subset of the authors (P.K.G., L.A.C., M.F.S., and
C.I.A.), as well as the following individuals: Salvatore Albani
(University of California, San Diego), S. Louis Bridges (Uni-
versity of Alabama at Birmingham), Leigh F. Callahan (Uni-
versity of North Carolina), Daniel O. Clegg (University of
Utah), Donald Flemming (Bethesda Naval Medical Center),
Daniel L. Kastner (National Institute of Arthritis and Mus-
culoskeletal and Skin Diseases), Marlene Kern (North Shore–
Long Island Jewish Research Institute), J. Lee Nelson (Fred
Hutchinson Cancer Research Center), Theodore Pincus (Van-
derbilt University), David S. Pisetsky (Duke University), Rich-
ard Pope (Northwestern University), HarryW. Schroeder (Uni-
versity of Alabama at Birmingham), Ryk Ward (Oxford
University), and Mark H. Wener (University of Washington).
Support for the NARAC is provided, in part, by the National
Arthritis Foundation. Finally, we wish to thank the patients
and families who made these studies possible through their
generous participation.
Electronic-Database Information
Accession numbers and URLs for data presented herein are
as follows:
Center for Medical Genetics, Marshfield Medical Research
Foundation, http://research.marshfieldclinic.org/genetics/Lab
_Methods/methods.htm
Immunogenetics/HLA Sequence Satabase, http://www.ebi.ac
.uk:80/imgt/hla/nomen.html
North American Rheumatoid Arthritis Consortium, http://
www.naracdata.org/
Online Mendelian Inheritance in Man (OMIM), http://www
.ncbi.nlm.nih.gov/Omim/ (for RA [180300], common var-
iable immunodeficiency [240500], IgA deficiency [137100],
systemic lupus erythematosus [152700], insulin-dependent
diabetes mellitus [222100], autoimmune hepatitis [142395],
and Epstein-Barr–virus disease [226990]
Sanger Institute, http://www.sanger.ac.uk/HGP/Chr6/MHC
.shtml (for HLA consensus sequence)
UCSC Genome Bioinformatics, http://www.genome.ucsc.edu
(for exact marker locations)
References
Alper CA, Kruskall MS, Marcus-Bagley D, Craven DE, Katz
AJ, Brink SJ, Dienstag JL, Awdeh Z, Yunis EJ (1989) Genetic
Jawaheer et al.: HLA Risk Factors in RA 593
prediction of nonresponse to hepatitis B vaccine. N Engl J
Med 321:708–712
Candore G, Cigna D, Gervasi F, Colucci AT, Modica MA,
Caruso C (1994) In vitro cytokine production by HLA-
B8,DR3 positive subjects. Autoimmunity 18:121–132
Caruso C, Candore G, Colucci AT, Cigna D, Sammartano F,
Ammatuna P (1993) HLA-B8,DR3 phenotype and the an-
tibody response against Epstein-Barr virus. Immunol Invest
22:41–51
Cornelis F, Faure S, Martinez M, Prud’homme JF, Fritz P, Dib
C, Alves H, et al (1998) New susceptibility locus for rheu-
matoid arthritis suggested by a genome-wide linkage study.
Proc Natl Acad Sci USA 95:10746–10750
Deighton CM, Walker DJ, Griffiths ID, Roberts DF (1989)
The contribution of HLA to rheumatoid arthritis. ClinGenet
36:178–182
Dizier MH, Eliaou JF, Babron MC, Combe B, Sany J, Clot J,
Clerget-Darpoux F (1993) Investigation of the HLA com-
ponent involved in rheumatoid arthritis (RA) by using the
marker association-segregation x2 (MASC) method: rejec-
tion of the unifying-shared-epitope hypothesis. Am J Hum
Genet 53:715–721
Erlich HA, Bugawan T, Begovich AB, Scharf S, Griffith R, Saiki
R, Higuchi R, Walsh PS (1991) HLA-DR, DQ and DP typing
using PCR amplification and immobilized probes. Eur J Im-
munogenet 18:33–55
Graham RR, Ortmann WA, Langefeld CD, Jawaheer D, Selby
SA, Rodine PR, Baechler EC, Rohlf KE, Shark KB, Nair RP,
Stuart PE, Elder JT, King RA, Moser KL, Gaffney PM, Bu-
gawan TL, Erlich HA, Rich SS, Gregersen PK, Behrens TW
(2002) Visualizing human leukocyte antigen class II risk hap-
lotypes in human systemic lupus erythematosus. Am J Hum
Genet 71:543–553 (in this issue)
Gregersen PK (1998) The North American Rheumatoid Ar-
thritis Consortium: bringing genetic analysis to bear on dis-
ease susceptibility, severity, and outcome. Arthritis Care Res
11:1–2
Gregersen PK, Silver J, Winchester RJ (1987) The shared ep-
itope hypothesis: an approach to understanding the molec-
ular genetics of susceptibility to rheumatoid arthritis. Ar-
thritis Rheum 30:1205–1213
Hall FC,Weeks DE, Camilleri JP,Williams LA, AmosN,Darke
C, Gibson K, Pile K, Wordsworth BP, Jessop JD (1996) In-
fluence of the HLA-DRB1 locus on susceptibility and se-
verity in rheumatoid arthritis. QJM 89:821–829
James JA, Neas BR, Moser KL, Hall T, Bruner GR, Sestak AL,
Harley JB (2001) Systemic lupus erythematosus in adults is
associated with previous Epstein-Barr virus exposure. Ar-
thritis Rheum 44:1122–1126
Jawaheer D, Seldin MF, Amos CI, Chen WV, Shigeta R, Mon-
teiro J, Kern M, Criswell LA, Albani S, Nelson JL, Clegg
DO, Pope R, Schroeder HW Jr, Bridges SL Jr, Pisetsky DS,
Ward R, Kastner DL, Wilder RL, Pincus T, Callahan LF,
Flemming D, Wener MH, Gregersen PK (2001) A genome-
wide screen in multiplex rheumatoid arthritis families sug-
gests genetic overlap with other autoimmune diseases. Am
J Hum Genet 68:927–936
Jeffreys AJ, Kauppi L, Neumann R (2001) Intensely punctate
meiotic recombination in the class II region of the major
histocompatibility complex. Nat Genet 29:217–222
Kaslow RA, Duquesnoy R, VanRaden M, Kingsley L, Marrari
M, Friedman H, Su S, et al (1990) A1, Cw7, B8, DR3 HLA
antigen combination associated with rapid decline of T-
helper lymphocytes in HIV-1 infection: a report from the
Multicenter AIDS Cohort Study. Lancet 335:927–930
Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES (1996) Par-
ametric and nonparametric linkage analysis: a unified mul-
tipoint approach. Am J Hum Genet 58:1347–1363
Lio D, Candore G, Colombo A, Colonna Romano G, Gervasi
F, Marino V, Scola L, Caruso C (2001) A genetically deter-
mined high setting of TNF-alpha influences immunologic
parameters of HLA-B8,DR3 positive subjects: implications
for autoimmunity. Hum Immunol 62:705–713
Martin ER, Monks SA, Warren LL, Kaplan NL (2000) A test
for linkage and association in general pedigrees: the pedigree
disequilibrium test. Am J Hum Genet 67:146–154
McDaniel DO, Alarcon GS, Pratt PW, Reveille JD (1995)Most
African-American patients with rheumatoid arthritis do not
have the rheumatoid antigenic determinant (epitope). Ann
Intern Med 123:181–187
MCH Sequencing Consortium (1999) Complete sequence and
gene map of a human major histocompatibility complex.
Nature 401:921–923
Milner CM, Campbell RD (2001) Genetic organization of the
human MHC class III region. Front Biosci Suppl 6:
D914–D926
Moxley G, Cohen HJ (2002) Genetic studies, clinical hetero-
geneity, and disease outcome studies in rheumatoid arthritis.
Rheum Dis Clin North Am 28:39–58
Mulcahy B, Waldron-Lynch F, McDermott MF, Adams C,
Amos CI, Zhu DK, Ward RH, Clegg DO, Shanahan F, Mol-
loy MG, O’Gara F (1996) Genetic variability in the tumor
necrosis factor-lymphotoxin region influences susceptibility
to rheumatoid arthritis. Am J Hum Genet 59:676–683
Nair RP, Stuart P, Henseler T, Jenisch S, Chia NV, Westphal
E, Schork NJ, Kim J, Lim HW, Christophers E, Voorhees
JJ, Elder JT (2000) Localization of psoriasis-susceptibility
locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am
J Hum Genet 66:1833–1844
Nepom GT, Seyfried CE, Holbeck SL, Wilske KR, Nepom BS
(1986) Identification of HLA-Dw14 genes in DR4 rheu-
matoid arthritis. Lancet 2:1002–1005
Ollier W, Thomson W (1992) Population genetics of rheu-
matoid arthritis. Rheum Dis Clin North Am 18:741–759
Ota M, Katsuyama Y, Kimura A, Tsuchiya K, Kondo M, Na-
ruse T, Mizuki N, Itoh K, Sasazuki T, Inoko H (2001) A
second susceptibility gene for developing rheumatoid ar-
thritis in the human MHC is localized within a 70-kb in-
terval telomeric of the TNF genes in the HLA class III region.
Genomics 71:263–270.
Price P, Witt C, Allcock R, Sayer D, Garlepp M, Kok CC,
French M, Mallal S, Christiansen F (1999) The genetic basis
for the association of the 8.1 ancestral haplotype (A1, B8,
DR3) with multiple immunopathological diseases. Immunol
Rev 167:257–274
Ronningen KS, Ploski R, Hansen T, Thorsby E (1992) Dw14
is a Dw4-independent risk factor for rheumatoid arthritis
among Norwegians. Tissue Antigens 39:280
Seldin MF, Amos CI, Ward R, Gregersen PK (1999) The ge-
594 Am. J. Hum. Genet. 71:585–594, 2002
netics revolution and the assault on rheumatoid arthritis.
Arthritis Rheum 42:1071–1079
Shannon CE (1948) The mathematical theory of communi-
cation. Bell Syst Tech J 27:623–656
Sobel E, Lange K (1996) Descent graphs in pedigree analysis:
applications to haplotyping, location scores, and marker-
sharing statistics. Am J Hum Genet 58:1323–1337
Stastny P (1978) Association of the B-cell alloantigen DRw4
with rheumatoid arthritis. N Engl J Med 298:869–871
Teller K, Budhai L, Zhang M, Haramati N, Keiser HD,
Davidson A (1996) HLA-DRB1 and DQB typing of His-
panic American patients with rheumatoid arthritis: the
“shared epitope” hypothesis may not apply. J Rheumatol
23:1363–1368
Thomson W, Harrison B, Ollier B, Wiles N, Payton T, Barrett
J, Symmons D, Silman A (1999) Quantifying the exact role
of HLA-DRB1 alleles in susceptibility to inflammatory poly-
arthritis: results from a large, population-based study. Ar-
thritis Rheum 42:757–762
Tosato G, Steinberg AD, Blaese RM (1981) Defective EBV-
specific suppressor T-cell function in rheumatoid arthritis.
N Engl J Med 305:1238–1243
Udalova IA, Nedospasov SA, Webb GC, Chaplin DD, Turet-
skaya RL (1993) Highly informative typing of the human
TNF locus using six adjacent polymorphic markers. Ge-
nomics 16:180–186
Waldron-Lynch F, Adams C, Amos C, Zhu DK, McDermott
MF, Shanahan F, Molloy MG, O’Gara F (2001) Tumour ne-
crosis factor 5′ promoter single nucleotide polymorphisms in-
fluence susceptibility to rheumatoid arthritis (RA) in immu-
nogenetically defined multiplex RA families. Genes Immun 2:
82–87
Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff
GW (1997) Effects of a polymorphism in the human tumor
necrosis factor alpha promoter on transcriptional activation.
Proc Natl Acad Sci USA 94:3195–3199
Yen JH, Moore BE, Nakajima T, Scholl D, Schaid DJ, Weyand
CM, Goronzy JJ (2001) Major histocompatibility complex
class I-recognizing receptors are disease risk genes in rheu-
matoid arthritis. J Exp Med 193:1159–1167
Zanelli E, Jones G, Pascual M, Eerligh P, van der Slik AR,
Zwinderman AH, Verduyn W, Schreuder GM, Roovers E,
Breedveld FC, de Vries RR, Martin J, Giphart MJ (2001)
The telomeric part of the HLA region predisposes to rheu-
matoid arthritis independently of the class II loci. Hum Im-
munol 62:75–84
